J&J to buy heart pump maker Abiomed in $16.6 billion dealBusiness, TherapeuticsJohnson & Johnson said on Tuesday it struck a deal to buy heart pump maker Abiomed Inc. for $16.6 billion in cash, as it looks to boost growth at its medical devices unit after next year’s planned spinoff of its consumer health business. Read more November 1, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/10/JJ-says-review-of-illness-that-led-to-pause-of-coronavirus-vaccine-trial-could-take-days-Reuters-10-12-20.jpeg 236 370 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-11-01 10:34:302022-11-01 11:16:49J&J to buy heart pump maker Abiomed in $16.6 billion deal